SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001213900-20-044656
Filing Date
2020-12-28
Accepted
2020-12-28 08:30:40
Documents
3
Effectiveness Date
2020-12-28

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ea132275-dfan14a_roumellasse.htm DFAN14A 95228
2 GRAPHIC image_001.jpg GRAPHIC 10907
3 GRAPHIC image_002.jpg GRAPHIC 40157
  Complete submission text file 0001213900-20-044656.txt   167347
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: DFAN14A | Act: 34 | File No.: 001-09974 | Film No.: 201414721
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences

Mailing Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815
Business Address 2 WISCONSIN CIR SUITE 640 CHEVY CHASE MD 20815 301-656-8500
Roumell Asset Management, LLC (Filed by) CIK: 0001331693 (see all company filings)

IRS No.: 522145132 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DFAN14A